다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Pharmacology, biochemistry, and behavior, v.98 no.1, 2011년, pp.81 - 86
Murphy, H.M. , Ihekoronze, C. , Wideman, C.H.
AI-Helper
Gamma aminobutyric acid (GABA)-A receptor modulators constitute the majority of clinically relevant sedative-hypnotics. Zolpidem (Ambien) is a nonbenzodiazepine GABA-A receptor modulator that binds with high affinity to GABA-A receptors expressing alpha-1 subunits. The present study examined the eff...
Physiol Behav Andrade 78 125 2003 10.1016/S0031-9384(02)00941-1 Longitudinal study of daily variation of rats' behavior in the elevated plus-maze
Neurosci Biobehav Rev Berridge 19 121 1995 10.1016/0149-7634(94)00026-W Benzodiazepines, appetite, and taste palatability
Appetite Cooper 44 133 2005 10.1016/j.appet.2005.01.003 Palatability-dependent appetite and benzodiazepines: new directions from the pharmacology of GABA-A receptor subtypes
Neurosci Biobehav Rev Cooper 9 5 1985 10.1016/0149-7634(85)90028-4 Behavioral pharmacology of food, water and salt intake in relation to drug actions at benzodiazepine receptors
Brain Res Cooper 456 173 1988 10.1016/0006-8993(88)90359-9 Clonazepam selectively increases saccharine ingestion in a two-choice test
Br J Pharmacol Crestani 131 1251 2000 10.1038/sj.bjp.0703717 Mechanism of action of the hypnotic zolpidem in vivo
J Neural Transm Cui 114 155 2007 10.1007/s00702-006-0535-1 Influence of diltiazem on the behavior of zolpidem-treated mice in the elevated-plus maze test
Curr Med Chem DaSettimo 14 2680 2007 10.2174/092986707782023190 GABA A/Bz receptor subtypes as targets for selective drugs
Pharmacol Biochem Behav Davies 49 47 1994 10.1016/0091-3057(94)90455-3 Evidence for central benzodiazepine receptor heterogenicity from behavior tests
Am J Med Doane 121 e5 2008 10.1016/j.amjmed.2008.04.035 Zolpidem-induced sleep-driving
Neuropharmacology Elliot 40 717 2001 10.1016/S0028-3908(00)00196-9 The acute effects of zolpidem compared to diazepam and lorazepam using radiotelemetry
Prog Neuropsychopharmacol Biol Psychiatry Gonzalez-Pardo 30 1020 2006 10.1016/j.pnpbp.2006.03.026 Oxidative metabolism of limbic structures after acute administration of diazepam, alprazolam, and zolpidem
Pharmacol Biochem Behav Hogg 54 21 1996 10.1016/0091-3057(95)02126-4 A review of the validity and variability of the elevated plus-maze as an animal model of anxiety
Drugs Holm 59 865 2000 10.2165/00003495-200059040-00014 Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia
Sleep Krystal 31 79 2008 10.1093/sleep/31.1.79 Long-term efficacy and safety of zolpidem extended-release 12.5mg, administered 3 to 7 nights per week for 24weeks, in patients with chronic primary insomnia: a 6-month randomized, double-blind, placebo-controlled, parallel-group, multicenter study
Eur Neuropsychopharmacol Langer 2 232 1992 10.1016/0924-977X(92)90081-I The selectivity of zolpidem and alpidem for the α1-subunit of the GABAA receptor
Drugs Langtry 40 291 1990 10.2165/00003495-199040020-00008 Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential
J Pharmacol Exp Ther Mohler 30 2 2002 10.1124/jpet.300.1.2 A new benzodiazepine pharmacology
Sleep Morairty 31 34 2008 10.1093/sleep/31.1.34 Selective 5HT2A and 5HT6 receptor antagonist promote sleep in rats
Appetite Morris 52 675 2009 10.1016/j.appet.2009.03.006 α1- and α2-containing GABAA receptor modulation is not necessary for benzodiazepine-induced hyperphagia
Br J Clin Pharmacol Nicholson 21 205 1986 10.1111/j.1365-2125.1986.tb05176.x Hypnotic activity of an imidazopyridine (zolpidem)
Brain Res Renger 1010 45 2004 10.1016/j.brainres.2004.02.067 Subchronic administration of zolpidem affects modifications to sleep architecture
Clin Pharmacokinet Salva 29 142 1995 10.2165/00003088-199529030-00002 Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications
Neuropharmacology Sanger 27 1125 1988 10.1016/0028-3908(88)90007-X Further behavioral evidence for the selective sedative action of zolpidem
Gen Hosp Psych Sansone 30 90 2008 10.1016/j.genhosppsych.2007.07.005 Zolpidem, somnambulism, and nocturnal eating
Psychopharmacology Stanhope 111 185 1993 10.1007/BF02245521 Effect of benzodiazepine receptor agonist, zolpidem, on palatable fluid consumption in the rat
Nutr Neurosci Wideman 12 233 2009 10.1179/147683009X423436 Constant light induces alterations in melatonin levels, food intake, feed efficiency, visceral adiposity, and circadian rhythms in rats
Br J Psychiatry Wilson 191 195 2007 10.1192/bjp.bp.107.036301 Management of insomnia: treatments and mechanisms
J Comp Physiol Psychol Wise 86 930 1974 10.1037/h0036404 Diazepam-induced eating and lever pressing for food in sated rats
Pharmacol Biochem Behav Yerbury 33 303 1989 10.1016/0091-3057(89)90504-2 Novel benzodiazepine receptor ligands: palatable food intake following zolpidem, CGS 17867A, or Ro23-0364, in the rat
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.